{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:11:53Z","timestamp":1792692713686,"version":"4.5.0"},"reference-count":246,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2018,5,12]],"date-time":"2018-05-12T00:00:00Z","timestamp":1526083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Since the Seven Countries Study, dietary cholesterol and the levels of serum cholesterol in relation to the development of chronic diseases have been somewhat demonised. However, the principles of the Mediterranean diet and relevant data linked to the examples of people living in the five blue zones demonstrate that the key to longevity and the prevention of chronic disease development is not the reduction of dietary or serum cholesterol but the control of systemic inflammation. In this review, we present all the relevant data that supports the view that it is inflammation induced by several factors, such as platelet-activating factor (PAF), that leads to the onset of cardiovascular diseases (CVD) rather than serum cholesterol. The key to reducing the incidence of CVD is to control the activities of PAF and other inflammatory mediators via diet, exercise, and healthy lifestyle choices. The relevant studies and data supporting these views are discussed in this review.<\/jats:p>","DOI":"10.3390\/nu10050604","type":"journal-article","created":{"date-parts":[[2018,5,14]],"date-time":"2018-05-14T02:57:20Z","timestamp":1526266640000},"page":"604","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":283,"title":["Inflammation, not Cholesterol, Is a Cause of Chronic Disease"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0837-9778","authenticated-orcid":false,"given":"Alexandros","family":"Tsoupras","sequence":"first","affiliation":[{"name":"Department of Biological Sciences, University of Limerick, V94 T9PX Limerick, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9668-3368","authenticated-orcid":false,"given":"Ronan","family":"Lordan","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, University of Limerick, V94 T9PX Limerick, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8175-950X","authenticated-orcid":false,"given":"Ioannis","family":"Zabetakis","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, University of Limerick, V94 T9PX Limerick, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,5,12]]},"reference":[{"key":"ref_1","unstructured":"Huff, T., and Jialal, I.I. (2017). Physiology, Cholesterol, StatPearls Publishing."},{"key":"ref_2","unstructured":"Walker, H.K., Hall, W.D., and Hurst, J.W. (1990). Cholesterol, triglycerides, and associated lipoproteins. Clinical Methods: The History, Physical, and Laboratory Examinations, Butterworths. [3rd ed.]."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Lordan, R., Tsoupras, A., Mitra, B., and Zabetakis, I. (2018). Dairy fats and cardiovascular disease: Do we really need to be concerned?. Foods, 7.","DOI":"10.3390\/foods7030029"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Upadhyay, R.K. (2015). Emerging risk biomarkers in cardiovascular diseases and disorders. J. Lipids, 2015.","DOI":"10.1155\/2015\/971453"},{"key":"ref_5","unstructured":"De Groot, L.J., Chrousos, G., Dungan, K., Feingold, K.R., Grossman, A., Hershman, J.M., Koch, C., Korbonits, M., McLachlan, R., and New, M. (2000). Risk Assessment and Guidelines for the Management of High Blood Cholesterol. Endotext, MDText.com, Inc."},{"key":"ref_6","unstructured":"De Groot, L.J., Chrousos, G., Dungan, K., Feingold, K.R., Grossman, A., Hershman, J.M., Koch, C., Korbonits, M., McLachlan, R., and New, M. (2000). The Measurement of Lipids, Lipoproteins, Apolipoproteins, Fatty Acids, and Sterols, and Next Generation Sequencing for the Diagnosis and Treatment of Lipid Disorders. Endotext, MDText.com, Inc."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1111\/bph.13743","article-title":"Current and future therapies for addressing the effects of inflammation on HDL cholesterol metabolism","volume":"174","author":"Iqbal","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1177\/039463201402700407","article-title":"Role of mast cells in atherosclerosis: A classical inflammatory disease","volume":"27","author":"Spinas","year":"2014","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.maturitas.2017.11.011","article-title":"Dietary management of dyslipidaemias. Is there any evidence for cardiovascular benefit?","volume":"108","author":"Anagnostis","year":"2018","journal-title":"Maturitas"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1520-037X.2003.01595.x","article-title":"Forty-Year Follow-Up of Coronary Heart Disease Mortality and Its Predictors: The Corfu Cohort of the Seven Countries Study","volume":"6","author":"Pitsavos","year":"2003","journal-title":"Prev. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s10654-007-9176-4","article-title":"Forty-year coronary mortality trends and changes in major risk factors in the first 10 years of follow-up in the seven countries study","volume":"22","author":"Menotti","year":"2007","journal-title":"Eur. J. Epidemiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1023\/A:1007529206050","article-title":"Food intake patterns and 25-year mortality from coronary heart disease: Cross-cultural correlations in the Seven Countries Study","volume":"15","author":"Menotti","year":"1999","journal-title":"Eur. J. Epidemiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00043798-199602000-00010","article-title":"Comparison of multivariate predictive power of major risk factors for coronary heart diseases in different countries: Results from eight nations of the Seven Countries Study, 25-year follow-up","volume":"3","author":"Menotti","year":"1996","journal-title":"J. Cardiovasc. Risk"},{"key":"ref_14","unstructured":"De Groot, L.J., Chrousos, G., Dungan, K., Feingold, K.R., Grossman, A., Hershman, J.M., Koch, C., Korbonits, M., McLachlan, R., and New, M. (2000). Cholesterol Lowering Drugs. Endotext, MDText.com, Inc."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e010401","DOI":"10.1136\/bmjopen-2015-010401","article-title":"Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: A systematic review","volume":"6","author":"Ravnskov","year":"2016","journal-title":"BMJ Open"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1002\/ijc.29938","article-title":"Dietary total fat and fatty acids intake, serum fatty acids and risk of breast cancer: A meta-analysis of prospective cohort studies","volume":"138","author":"Cao","year":"2016","journal-title":"Int. J. Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1080\/01635581.2016.1206582","article-title":"Effects of Serum Triglycerides on Prostate Cancer and Breast Cancer Risk: A Meta-Analysis of Prospective Studies","volume":"68","author":"Ma","year":"2016","journal-title":"Nutr. Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Ni, H., Liu, H., and Gao, R. (2015). Serum Lipids and Breast Cancer Risk: A Meta-Analysis of Prospective Cohort Studies. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0142669"},{"key":"ref_19","first-page":"155","article-title":"Serum cholesterol in cross-cultural perspective. The Seven Countries Study","volume":"54","author":"Kromhout","year":"1999","journal-title":"Acta Cardiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/jhn.12187","article-title":"Coronary heart disease mortality in relation to dietary, lifestyle and biochemical risk factors in the countries of the Seven Countries Study: A secondary dataset analysis","volume":"27","author":"Papandreou","year":"2014","journal-title":"J. Hum. Nutr. Diet."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.atherosclerosis.2015.08.039","article-title":"A Mediterranean diet and risk of myocardial infarction, heart failure and stroke: A population-based cohort study","volume":"243","author":"Tektonidis","year":"2015","journal-title":"Atherosclerosis"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/0140-6736(92)91277-F","article-title":"Wine, alcohol, platelets, and the French paradox for coronary heart disease","volume":"339","author":"Renaud","year":"1992","journal-title":"Lancet"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"913S","DOI":"10.3945\/jn.115.219147","article-title":"Intervention Trials with the Mediterranean Diet in Cardiovascular Prevention: Understanding Potential Mechanisms through Metabolomic Profiling","volume":"146","author":"Hruby","year":"2016","journal-title":"J. Nutr."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"491","DOI":"10.7326\/M16-0361","article-title":"Effects on Health Outcomes of a Mediterranean Diet With No Restriction on Fat Intake: A Systematic Review and Meta-analysis","volume":"165","author":"Bloomfield","year":"2016","journal-title":"Ann. Intern. Med."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Sanches Machado d\u2019Almeida, K., Ronchi Spillere, S., Zuchinali, P., and Correa Souza, G. (2018). Mediterranean Diet and Other Dietary Patterns in Primary Prevention of Heart Failure and Changes in Cardiac Function Markers: A Systematic Review. Nutrients, 10.","DOI":"10.3390\/nu10010058"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"403","DOI":"10.21873\/cgp.20050","article-title":"Impact of Mediterranean Diet on Cancer: Focused Literature Review","volume":"14","author":"Barak","year":"2017","journal-title":"Cancer Genom. Proteom."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.numecd.2014.03.003","article-title":"Mediterranean dietary pattern, inflammation and endothelial function: A systematic review and meta-analysis of intervention trials","volume":"24","author":"Schwingshackl","year":"2014","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/10408398.2013.852510","article-title":"The anticancer and antiobesity effects of Mediterranean diet","volume":"57","author":"Kwan","year":"2017","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"8947","DOI":"10.18632\/oncotarget.13553","article-title":"Impact of Mediterranean diet on metabolic syndrome, cancer and longevity","volume":"8","author":"Noce","year":"2017","journal-title":"Oncotarget"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1080\/09637486.2016.1221900","article-title":"Adherence to the Mediterranean diet is inversely associated with metabolic syndrome occurrence: A meta-analysis of observational studies","volume":"68","author":"Godos","year":"2017","journal-title":"Int. J. Food Sci. Nutr."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Salas-Salvado, J., Guasch-Ferre, M., Lee, C.H., Estruch, R., Clish, C.B., and Ros, E. (2016). Protective Effects of the Mediterranean Diet on Type 2 Diabetes and Metabolic Syndrome. J. Nutr.","DOI":"10.3945\/jn.115.218487"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Alkhatib, A., Tsang, C., Tiss, A., Bahorun, T., Arefanian, H., Barake, R., Khadir, A., and Tuomilehto, J. (2017). Functional Foods and Lifestyle Approaches for Diabetes Prevention and Management. Nutrients, 9.","DOI":"10.3390\/nu9121310"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s13679-017-0284-5","article-title":"Dietary Patterns and Cardiovascular Disease Risk in People with Type 2 Diabetes","volume":"6","author":"Subhan","year":"2017","journal-title":"Curr. Obes. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.3945\/jn.116.242552","article-title":"Dietary Patterns and Type 2 Diabetes: A Systematic Literature Review and Meta-Analysis of Prospective Studies","volume":"147","author":"Jannasch","year":"2017","journal-title":"J. Nutr."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10654-017-0338-8","article-title":"Diet and risk of diabetic retinopathy: A systematic review","volume":"33","author":"Dow","year":"2018","journal-title":"Eur. J. Epidemiol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Guilleminault, L., Williams, E.J., Scott, H.A., Berthon, B.S., Jensen, M., and Wood, L.G. (2017). Diet and Asthma: Is It Time to Adapt Our Message?. Nutrients, 9.","DOI":"10.3390\/nu9111227"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Forsyth, C., Kouvari, M., D\u2019Cunha, N.M., Georgousopoulou, E.N., Panagiotakos, D.B., Mellor, D.D., Kellett, J., and Naumovski, N. (2017). The effects of the Mediterranean diet on rheumatoid arthritis prevention and treatment: A systematic review of human prospective studies. Rheumatol. Int.","DOI":"10.1007\/s00296-017-3912-1"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Kojima, G., Avgerinou, C., Iliffe, S., and Walters, K. (2018). Adherence to Mediterranean Diet Reduces Incident Frailty Risk: Systematic Review and Meta-Analysis. J. Am. Geriatr. Soc.","DOI":"10.1111\/jgs.15251"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Suarez, M., Boque, N., Del Bas, J.M., Mayneris-Perxachs, J., Arola, L., and Caimari, A. (2017). Mediterranean Diet and Multi-Ingredient-Based Interventions for the Management of Non-Alcoholic Fatty Liver Disease. Nutrients, 9.","DOI":"10.3390\/nu9101052"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/liv.13435","article-title":"The Mediterranean dietary pattern as the diet of choice for non-alcoholic fatty liver disease: Evidence and plausible mechanisms","volume":"37","author":"Salomone","year":"2017","journal-title":"Liver Int."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11894-017-0563-z","article-title":"The Role of Diet in Inflammatory Bowel Disease","volume":"19","author":"Shivashankar","year":"2017","journal-title":"Curr. Gastroenterol. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Aridi, Y.S., Walker, J.L., and Wright, O.R.L. (2017). The Association between the Mediterranean Dietary Pattern and Cognitive Health: A Systematic Review. Nutrients, 9.","DOI":"10.3390\/nu9070674"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"6144","DOI":"10.1007\/s12035-015-9516-4","article-title":"Dietary Patterns and Risk of Dementia: A Systematic Review and Meta-Analysis of Cohort Studies","volume":"53","author":"Cao","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"889","DOI":"10.3945\/an.116.012138","article-title":"Mediterranean Diet, Cognitive Function, and Dementia: A Systematic Review of the Evidence","volume":"7","author":"Petersson","year":"2016","journal-title":"Adv. Nutr."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"6469138","DOI":"10.1155\/2017\/6469138","article-title":"Nutritional and Lifestyle Interventions for Age-Related Macular Degeneration: A Review","volume":"2017","author":"Carneiro","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"442","DOI":"10.2174\/1570161114999160719104731","article-title":"The Mediterranean and other Dietary Patterns in Secondary Cardiovascular Disease Prevention: A Review","volume":"14","author":"Panagiotakos","year":"2016","journal-title":"Curr. Vasc. Pharmacol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/01.CIR.99.6.779","article-title":"Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: Final report of the Lyon Diet Heart Study","volume":"99","author":"Salen","year":"1999","journal-title":"Circulation"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/jama.292.12.1433","article-title":"Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: The HALE project","volume":"292","author":"Knoops","year":"2004","journal-title":"JAMA"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-nutr-011215-025104","article-title":"Mediterranean Dietary Patterns and Cardiovascular Health","volume":"35","author":"Shen","year":"2015","journal-title":"Annu. Rev. Nutr."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Sofi, F., Dinu, M., Pagliai, G., Cesari, F., Gori, A.M., Sereni, A., Becatti, M., Fiorillo, C., Marcucci, R., and Casini, A. (2018). Low-Calorie Vegetarian Versus Mediterranean Diets for Reducing Body Weight and Improving Cardiovascular Risk Profile: CARDIVEG Study (Cardiovascular Prevention With Vegetarian Diet). Circulation.","DOI":"10.1161\/CIRCULATIONAHA.117.030088"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3945\/an.115.009753","article-title":"Dietary Patterns and Blood Pressure in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"7","author":"Ndanuko","year":"2016","journal-title":"Adv. Nutr."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S2213-8587(16)30085-7","article-title":"Effect of a high-fat Mediterranean diet on bodyweight and waist circumference: A prespecified secondary outcomes analysis of the PREDIMED randomised controlled trial","volume":"4","author":"Estruch","year":"2016","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1161\/CIRCULATIONAHA.116.023712","article-title":"Mediterranean diet improves high-density lipoprotein function in high-cardiovascular-risk individuals: A randomized controlled trial","volume":"135","author":"Elosua","year":"2017","journal-title":"Circulation"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/ajcn\/80.4.1012","article-title":"Olive oil, the Mediterranean diet, and arterial blood pressure: The Greek European Prospective Investigation into Cancer and Nutrition (EPIC) study","volume":"80","author":"Psaltopoulou","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-145-1-200607040-00004","article-title":"Effects of a Mediterranean-style diet on cardiovascular risk factors: A randomized trial","volume":"145","author":"Estruch","year":"2006","journal-title":"Ann. Intern. Med."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Lordan, R., Tsoupras, A., and Zabetakis, I. (2017). Phospholipids of Animal and Marine Origin: Structure, Function, and Anti-Inflammatory Properties. Molecules, 22.","DOI":"10.20944\/preprints201711.0038.v1"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"390","DOI":"10.2174\/187152609788922555","article-title":"The Implication of platelet-activating factor in cancer growth and metastasis: Potent beneficial role of PAF-inhibitors and antioxidants","volume":"9","author":"Tsoupras","year":"2009","journal-title":"Infect. Disord. Drug Targets"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/ejlt.200300845","article-title":"Platelet activating factor\u2014A molecular link between atherosclerosis theories","volume":"105","author":"Demopoulos","year":"2003","journal-title":"Eur. J. Lipid Sci. Technol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1007\/s00018-013-1289-1","article-title":"Inflammation and immune system interactions in atherosclerosis","volume":"70","author":"Legein","year":"2013","journal-title":"Cellular Mol. Life Sci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"9746169","DOI":"10.1155\/2017\/9746169","article-title":"Leukocyte Trafficking in Cardiovascular Disease: Insights from Experimental Models","volume":"2017","author":"Jones","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev.immunol.021908.132620","article-title":"Immune and Inflammatory Mechanisms of Atherosclerosis","volume":"27","author":"Galkina","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1161\/CIRCRESAHA.116.301313","article-title":"Inflammation and Immunity in Diseases of the Arterial Tree: Players and Layers","volume":"116","author":"Libby","year":"2015","journal-title":"Circ. Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1111\/bph.13805","article-title":"Vascular inflammation and low-density lipoproteins: Is cholesterol the link? A lesson from the clinical trials","volume":"174","author":"Catapano","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Ma, X., and Feng, Y. (2016). Hypercholesterolemia Tunes Hematopoietic Stem\/Progenitor Cells for Inflammation and Atherosclerosis. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17071162"},{"key":"ref_65","unstructured":"De Groot, L.J., Chrousos, G., Dungan, K., Feingold, K.R., Grossman, A., Hershman, J.M., Koch, C., Korbonits, M., McLachlan, R., and New, M. (2000). The Effect of Inflammation and Infection on Lipids and Lipoproteins. Endotext, MDText.com, Inc."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/icb.2015.26","article-title":"Inflammation-induced foam cell formation in chronic inflammatory disease","volume":"93","author":"Angelovich","year":"2015","journal-title":"Immunol. Cell Biol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.biochi.2010.02.011","article-title":"The platelet activating factor (PAF) signaling cascade in systemic inflammatory responses","volume":"92","author":"Yost","year":"2010","journal-title":"Biochimie"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1476-9255-8-17","article-title":"In vitro anti-inflammatory and anti-coagulant effects of antibiotics towards Platelet Activating Factor and thrombin","volume":"8","author":"Tsoupras","year":"2011","journal-title":"J. Inflamm."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1476-511X-13-90","article-title":"In vivo effect of two first-line ART regimens on inflammatory mediators in male HIV patients","volume":"13","author":"Papakonstantinou","year":"2014","journal-title":"Lipids Health Dis."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1177\/0003319711420608","article-title":"Platelet-Activating Factor and Its Basic Metabolic Enzymes in Blood of Naive HIV-Infected Patients","volume":"63","author":"Tsoupras","year":"2012","journal-title":"Angiology"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1089\/aid.2007.0263","article-title":"Anti-platelet-activating factor effects of highly active antiretroviral therapy (HAART): A new insight in the drug therapy of HIV infection?","volume":"24","author":"Tsoupras","year":"2008","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/039463201202500127","article-title":"Effects of highly active antiretroviral therapy on platelet activating factor metabolism in naive HIV-infected patients: II) study of the abacavir\/lamivudine\/efavirenz HAART regimen","volume":"25","author":"Chini","year":"2012","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1089\/aid.2011.0202","article-title":"Effects of HAART on platelet-activating factor metabolism in naive HIV-infected patients I: Study of the tenofovir-DF\/emtricitabine\/efavirenz HAART regimen","volume":"28","author":"Chini","year":"2012","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/1721727X1100900204","article-title":"In vivo effects of a Ginkgo biloba extract on platelet activating factor metabolism in two asymptomatic HIV-infected patients","volume":"9","author":"Tsoupras","year":"2011","journal-title":"Eur. J. Inflamm."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1177\/10454411000110020701","article-title":"PAF, a putative mediator of oral inflammation","volume":"11","author":"McManus","year":"2000","journal-title":"Crit. Rev. Oral Biol. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/j.lfs.2006.06.009","article-title":"Isolation and identification of hydroxyl\u2013platelet-activating factor from natural sources","volume":"79","author":"Tsoupras","year":"2006","journal-title":"Life Sci."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/09629350310001599666","article-title":"Hydroxyl-platelet-activating factor exists in blood of healthy volunteers and periodontal patients","volume":"12","author":"Antonopoulou","year":"2003","journal-title":"Mediat. Inflamm."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.ajpath.2014.11.025","article-title":"The Role of Platelet-Activating Factor in Mesangial Pathophysiology","volume":"185","author":"Reznichenko","year":"2015","journal-title":"Am. J. Pathol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"87","DOI":"10.5301\/ijao.5000187","article-title":"Paricalcitol effects on activities and metabolism of Platelet Activating Factor and on inflammatory cytokines in hemodialysis patients","volume":"36","author":"Verouti","year":"2013","journal-title":"Int. J. Artif. Organs"},{"key":"ref_80","first-page":"105","article-title":"In vitro protective effects of olive pomace polar lipids towards platelet activating factor metabolism in human renal cells","volume":"9","author":"Tsoupras","year":"2011","journal-title":"Curr. Top. Nutraceutical Res."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Tsoupras, A.B., Fragopoulou, E., Nomikos, T., Iatrou, C., Antonopoulou, S., and Demopoulos, C.A. (2007). Characterization of the de novo biosynthetic enzyme of platelet activating factor, DDT-insensitive cholinephosphotransferase, of human mesangial cells. Mediat. Inflamm., 2007.","DOI":"10.1155\/2007\/27683"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ijcard.2017.01.072","article-title":"Traditional cardiovascular risk factors or inflammation: Which factors accelerate atherosclerosis in arthritis patients?","volume":"236","author":"Dalbeni","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1111\/bph.13818","article-title":"Targeting inflammation to reduce cardiovascular disease risk: A realistic clinical prospect?","volume":"174","author":"Welsh","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/CIRCRESAHA.111.257535","article-title":"Multiple Roles for Neutrophils in Atherosclerosis","volume":"110","author":"Soehnlein","year":"2012","journal-title":"Circ. Res."},{"key":"ref_85","first-page":"191","article-title":"The Role of Platelet-Activating Factor in Chronic Inflammation, Immune Activation, and Comorbidities Associated with HIV Infection","volume":"17","author":"Kelesidis","year":"2015","journal-title":"AIDS Rev."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"9355","DOI":"10.1016\/S0021-9258(19)83523-8","article-title":"Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators)","volume":"254","author":"Demopoulos","year":"1979","journal-title":"J. Biol. Chem."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0090-6980(02)00058-8","article-title":"Platelet-activating factor receptor","volume":"68\u201369","author":"Ishii","year":"2002","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/oxfordjournals.jbchem.a003164","article-title":"Platelet-activating factor receptor","volume":"131","author":"Honda","year":"2002","journal-title":"J. Biochem."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/1755-5922.12233","article-title":"Platelet activating factor: A potential biomarker in acute coronary syndrome?","volume":"35","author":"Varghese","year":"2017","journal-title":"Cardiovasc. Ther."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1172\/JCI117726","article-title":"Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein","volume":"95","author":"Watson","year":"1995","journal-title":"J. Clin. Investig."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1194\/jlr.M700598-JLR200","article-title":"Polyunsaturated phospholipids promote the oxidation and fragmentation of gamma-hydroxyalkenals: Formation and reactions of oxidatively truncated ether phospholipids","volume":"49","author":"Chen","year":"2008","journal-title":"J. Lipid Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0022-2275(20)39691-7","article-title":"Platelet-activating factor: A phospholipid autacoid with diverse actions","volume":"34","author":"Venable","year":"1993","journal-title":"J. Lipid Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.plipres.2016.03.004","article-title":"Understanding the connection between platelet-activating factor, a UV-induced lipid mediator of inflammation, immune suppression and skin cancer","volume":"63","author":"Damiani","year":"2016","journal-title":"Prog. Lipid Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/prot.21213","article-title":"Understanding the regulation mechanisms of PAF receptor by agonists and antagonists: Molecular modeling and molecular dynamics simulation studies","volume":"67","author":"Gui","year":"2007","journal-title":"Proteins"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1194\/jlr.M800263-JLR200","article-title":"Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons","volume":"49","author":"Ryan","year":"2008","journal-title":"J. Lipid Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1016\/j.bbamem.2012.03.004","article-title":"Bioactive oxidatively truncated phospholipids in inflammation and apoptosis: Formation, targets, and inactivation","volume":"1818","author":"McIntyre","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1152\/physrev.2000.80.4.1669","article-title":"Role of platelet-activating factor in cardiovascular pathophysiology","volume":"80","author":"Montrucchio","year":"2000","journal-title":"Physiol. Rev."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1590\/S0074-02762005000900014","article-title":"Regulating inflammation through the anti-inflammatory enzyme platelet-activating factor-acetylhydrolase","volume":"100","author":"Stafforini","year":"2005","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"660","DOI":"10.4049\/jimmunol.147.2.660","article-title":"Differential synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine and platelet-activating factor by human inflammatory cells","volume":"147","author":"Triggiani","year":"1991","journal-title":"J. Immunol."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Francescangeli, E., Freysz, L., and Goracci, G. (1996). PAF-Synthesizing Enzymes in Neural Cells during Differentiation and in Gerbil Brain during Ischemia. Platelet-Activating Factor and Related Lipid Mediators 2, Springer.","DOI":"10.1007\/978-1-4899-0179-8_5"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1194\/jlr.M049205","article-title":"Selective inhibitors of a PAF biosynthetic enzyme lysophosphatidylcholine acyltransferase 2","volume":"55","author":"Tarui","year":"2014","journal-title":"J. Lipid Res."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/jb\/mvt048","article-title":"Generation of membrane diversity by lysophospholipid acyltransferases","volume":"154","author":"Shindou","year":"2013","journal-title":"J. Biochem."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-511X-10-213","article-title":"Fish polar lipids retard atherosclerosis in rabbits by down-regulating PAF biosynthesis and up-regulating PAF catabolism","volume":"10","author":"Nasopoulou","year":"2011","journal-title":"Lipids Health Dis."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.clinbiochem.2008.09.113","article-title":"Platelet activating factor (PAF) and activity of its biosynthetic and catabolic enzymes in blood and leukocytes of male patients with newly diagnosed heart failure","volume":"42","author":"Detopoulou","year":"2009","journal-title":"Clin. Biochem."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1537-1891(02)00169-6","article-title":"Activation of vascular cells by PAF-like lipids in oxidized LDL","volume":"38","author":"Marathe","year":"2002","journal-title":"Vasc. Pharmacol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S1050-1738(01)00100-1","article-title":"Oxidized LDL Contains Inflammatory PAF-Like Phospholipids","volume":"11","author":"Marathe","year":"2001","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10557-008-6133-8","article-title":"Biology of Platelet-activating Factor Acetylhydrolase (PAF-AH, Lipoprotein Associated Phospholipase A2)","volume":"23","author":"Stafforini","year":"2009","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.enz.2015.09.006","article-title":"Overview of PAF-degrading enzymes","volume":"38","author":"Karasawa","year":"2015","journal-title":"The Enzymes"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1194\/jlr.E052886","article-title":"Unraveling the PAF-AH\/Lp-PLA(2) controversy","volume":"55","author":"Stafforini","year":"2014","journal-title":"J. Lipid Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"6256","DOI":"10.2174\/1381612820666140622200916","article-title":"Pathophysiological role and clinical significance of lipoprotein-associated phospholipase A2 (Lp-PLA2) bound to LDL and HDL","volume":"20","author":"Tellis","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/bs.enz.2015.09.007","article-title":"Intracellular PAF-acetylhydrolase type I","volume":"38","author":"Hattori","year":"2015","journal-title":"The Enzymes"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/bs.enz.2015.09.008","article-title":"Intracellular platelet-activating factor acetylhydrolase, type II: A unique cellular phospholipase A2 that hydrolyzes oxidatively modified phospholipids","volume":"38","author":"Kono","year":"2015","journal-title":"The Enzymes"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.neubiorev.2013.06.010","article-title":"Platelet activating factors in depression and coronary artery disease: A potential biomarker related to inflammatory mechanisms and neurodegeneration","volume":"37","author":"Mazereeuw","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10555-007-9092-9","article-title":"Inflammation and melanoma growth and metastasis: The role of platelet-activating factor (PAF) and its receptor","volume":"26","author":"Melnikova","year":"2007","journal-title":"Cancer Metastasis Rev."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart Disease and Stroke Statistics\u20142017 Update: A Report From the American Heart Association","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1113\/jphysiol.2011.225417","article-title":"Platelets: A critical link between inflammation and microvascular dysfunction","volume":"590","author":"Stokes","year":"2012","journal-title":"J. Physiol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3109\/09537104.2015.1064881","article-title":"The role of platelets in the recruitment of leukocytes during vascular disease","volume":"26","author":"Chimen","year":"2015","journal-title":"Platelets"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.bbalip.2006.05.014","article-title":"Cytokine-induced monocyte adhesion to endothelial cells involves platelet-activating factor: Suppression by conjugated linoleic acid","volume":"1761","author":"Sneddon","year":"2006","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"ref_119","first-page":"51","article-title":"The Role of Platelets in Atherothrombosis","volume":"2011","author":"Kaplan","year":"2011","journal-title":"ASH Educ. Program Book"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1160\/TH14-08-0662","article-title":"Intravascular leukocyte migration through platelet thrombi: Directing leukocytes to sites of vascular injury","volume":"113","author":"Ghasemzadeh","year":"2015","journal-title":"Thromb. Haemost."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1749-6632.2010.05733.x","article-title":"Platelet\u2013leukocyte interactions link inflammatory and thromboembolic events in ischemic stroke","volume":"1207","author":"Franks","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_122","first-page":"185","article-title":"Inflammation: A trigger for acute coronary syndrome","volume":"60","author":"Sager","year":"2016","journal-title":"Q. J. Nucl. Med. Mol. Imaging"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00424-017-1941-y","article-title":"Macrophages in vascular inflammation and atherosclerosis","volume":"469","author":"Cochain","year":"2017","journal-title":"Pfl\u00fcgers Archiv Eur. J. Physiol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"693083","DOI":"10.1155\/2012\/693083","article-title":"Diverse Roles of Macrophages in Atherosclerosis: From Inflammatory Biology to Biomarker Discovery","volume":"2012","author":"Gui","year":"2012","journal-title":"Mediat. Inflamm."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1159\/000327962","article-title":"Pivotal Role for Platelet-Activating Factor Receptor in CD36 Expression and oxLDL Uptake by Human Monocytes\/Macrophages","volume":"27","author":"Rios","year":"2011","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nri3908","article-title":"How leukocytes cross the vascular endothelium","volume":"15","author":"Vestweber","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1016\/j.febslet.2005.06.022","article-title":"Platelet activating factor induces cytoskeletal reorganization through Rho family pathway in THP-1 macrophages","volume":"579","author":"Sumita","year":"2005","journal-title":"FEBS Lett."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.immuni.2004.09.003","article-title":"Dyslipidemia Associated with Atherosclerotic Disease Systemically Alters Dendritic Cell Mobilization","volume":"21","author":"Angeli","year":"2004","journal-title":"Immunity"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.plefa.2013.09.003","article-title":"Activation of PAF-receptor induces regulatory dendritic cells through PGE2 and IL-10","volume":"89","author":"Koga","year":"2013","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1160\/TH12-11-0819","article-title":"CD4+ T cells in atherosclerosis: Regulation by platelets","volume":"109","author":"Li","year":"2013","journal-title":"Thromb. Haemost."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/ni943","article-title":"Thromboxane A2 modulates interaction of dendritic cells and T cells and regulates acquired immunity","volume":"4","author":"Kabashima","year":"2003","journal-title":"Nat. Immunol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1146\/annurev.biochem.69.1.419","article-title":"Platelet-activating factor and related lipid mediators","volume":"69","author":"Prescott","year":"2000","journal-title":"Annu. Rev. Biochem."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1161\/01.ATV.17.5.963","article-title":"Platelet-Activating Factor and Oxidized LDL Induce Immune Activation by a Common Mechanism","volume":"17","author":"Huang","year":"1997","journal-title":"Arterioscl. Thromb. Vasc. Biol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2165\/00003495-199142010-00002","article-title":"Platelet activating factor (PAF). A review of its effects, antagonists and possible future clinical implications (Part I)","volume":"42","author":"Koltai","year":"1991","journal-title":"Drugs"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"174","DOI":"10.2165\/00003495-199142020-00002","article-title":"PAF. A review of its effects, antagonists and possible future clinical implications (Part II)","volume":"42","author":"Koltai","year":"1991","journal-title":"Drugs"},{"key":"ref_136","first-page":"249","article-title":"Platelet-activating factor antagonists","volume":"25","year":"1997","journal-title":"Allergol. Immunopathol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.fitote.2012.11.002","article-title":"Platelet-activating factor (PAF)-antagonists of natural origin","volume":"84","author":"Singh","year":"2013","journal-title":"Fitoterapia"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0929-7855(96)00562-7","article-title":"Platelet-activating factor and cardiac diseases: Therapeutic potential for PAF inhibitors","volume":"15","author":"Feuerstein","year":"1997","journal-title":"J. Lipid Mediat. Cell Signal."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3109\/08941939709099596","article-title":"Platelet-activating factor antagonism: A new concept in the management of regional myocardial ischemia-reperfusion injury","volume":"10","author":"Loucks","year":"1997","journal-title":"J. Investig. Surg."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Papakonstantinou, V.D., Lagopati, N., Tsilibary, E.C., Demopoulos, C.A., and Philippopoulos, A.I. (2017). A Review on Platelet Activating Factor Inhibitors: Could a New Class of Potent Metal-Based Anti-Inflammatory Drugs Induce Anticancer Properties?. Bioinorg. Chem. Appl., 2017.","DOI":"10.1155\/2017\/6947034"},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Fragopoulou, E., Choleva, M., Antonopoulou, S., and Demopoulos, C.A. (2018). Wine and its metabolic effects. A comprehensive review of Clinical Trials. Metabolism.","DOI":"10.1016\/j.metabol.2018.01.024"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.foodchem.2009.11.023","article-title":"In vivo anti-atherogenic properties of cultured gilthead sea bream (Sparus aurata) polar lipid extracts in hypercholesterolaemic rabbits","volume":"120","author":"Nasopoulou","year":"2010","journal-title":"Food Chem."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.numecd.2009.06.008","article-title":"Atherosclerosis regression study in rabbits upon olive pomace polar lipid extract administration","volume":"20","author":"Tsantila","year":"2010","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Tsantila, N., Karantonis, H.C., Perrea, D.N., Theocharis, S.E., Iliopoulos, D.G., Antonopoulou, S., and Demopoulos, C.A. (2007). Antithrombotic and antiatherosclerotic properties of olive oil and olive pomace polar extracts in rabbits. Mediat. Inflamm., 2007.","DOI":"10.1155\/2007\/36204"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.numecd.2005.07.003","article-title":"In vivo antiatherogenic properties of olive oil and its constituent lipid classes in hyperlipidemic rabbits","volume":"16","author":"Karantonis","year":"2006","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Argyrou, C., Vlachogianni, I., Stamatakis, G., Demopoulos, C.A., Antonopoulou, S., and Fragopoulou, E. (2017). Postprandial effects of wine consumption on Platelet Activating Factor metabolic enzymes. Prostaglandins Other Lipid Mediat.","DOI":"10.1016\/j.prostaglandins.2017.03.002"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00394-016-1194-0","article-title":"Wine consumption reduced postprandial platelet sensitivity against platelet activating factor in healthy men","volume":"56","author":"Xanthopoulou","year":"2017","journal-title":"Eur. J. Nutr."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.foodchem.2014.05.085","article-title":"Effect of Robola and Cabernet Sauvignon extracts on platelet activating factor enzymes activity on U937 cells","volume":"165","author":"Xanthopoulou","year":"2014","journal-title":"Food Chem."},{"key":"ref_149","unstructured":"Fragopoulou, E., Antonopoulou, S., Tsoupras, A., Tsantila, N., Grypioti, A., Gribilas, G., Gritzapi, H., Konsta, E., Skandalou, E., and Papadopoulou, A. (2004, January 25\u201329). Antiatherogenic properties of red\/white wine, musts, grape-skins, and yeast. Proceedings of the 45th International Conference on the Bioscience of Lipids, University of Ioannina, Ioannina, Greece."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"5186","DOI":"10.1021\/jf0106392","article-title":"Biological activity of total lipids from red and white wine\/must","volume":"49","author":"Fragopoulou","year":"2001","journal-title":"J. Agric. Food Chem."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1021\/jf990554p","article-title":"Separation of Biologically Active Lipids from Red Wine","volume":"48","author":"Fragopoulou","year":"2000","journal-title":"J. Agric. Food. Chem."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"6372","DOI":"10.1021\/jf000701f","article-title":"Lipid fractions with aggregatory and antiaggregatory activity toward platelets in fresh and fried cod (Gadus morhua):\u2009 correlation with platelet-activating factor and atherogenesis","volume":"48","author":"Panayiotou","year":"2000","journal-title":"J. Agric. Food. Chem."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.foodres.2016.03.015","article-title":"Structure and cardioprotective activities of polar lipids of olive pomace, olive pomace-enriched fish feed and olive pomace fed gilthead sea bream (Sparus aurata)","volume":"83","author":"Sioriki","year":"2016","journal-title":"Food Res. Int."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1080\/10498850.2013.813100","article-title":"Comparison of sensory and cardioprotective properties of olive-pomace enriched and conventional gilthead sea bream (Sparus aurata): The effect of grilling","volume":"24","author":"Sioriki","year":"2015","journal-title":"J. Aquat. Food Prod. Technol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.foodchem.2013.08.091","article-title":"Structural elucidation of olive pomace fed sea bass (Dicentrarchus labrax) polar lipids with cardioprotective activities","volume":"145","author":"Nasopoulou","year":"2014","journal-title":"Food Chem."},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Nasopoulou, C., Gogaki, V., Stamatakis, G., Papaharisis, L., Demopoulos, C., and Zabetakis, I. (2013). Evaluation of the in Vitro Anti-Atherogenic Properties of Lipid Fractions of Olive Pomace, Olive Pomace Enriched Fish Feed and Gilthead Sea Bream (Sparus aurata) Fed with Olive Pomace Enriched Fish Feed. Mar. Drugs, 11.","DOI":"10.3390\/md11103676"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.foodchem.2011.05.086","article-title":"Effects of olive pomace and olive pomace oil on growth performance, fatty acid composition and cardio protective properties of gilthead sea bream (Sparus aurata) and sea bass (Dicentrarchus labrax)","volume":"129","author":"Nasopoulou","year":"2011","journal-title":"Food Chem."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.foodchem.2008.04.011","article-title":"Antibacterial and anti-PAF activity of lipid extracts from sea bass (Dicentrarchus labrax) and gilthead sea bream (Sparus aurata)","volume":"111","author":"Nasopoulou","year":"2008","journal-title":"Food Chem."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.foodchem.2005.09.074","article-title":"Comparison of antiatherogenic properties of lipids obtained from wild and cultured sea bass (Dicentrarchus labrax) and gilthead sea bream (Sparus aurata)","volume":"100","author":"Nasopoulou","year":"2007","journal-title":"Food Chem."},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Rementzis, J., Antonopoulou, S., Argyropoulos, D., and Demopoulos, C.A. (1996). Biologically active lipids from S. scombrus. Platelet-Activating Factor and Related Lipid Mediators 2, Springer.","DOI":"10.1007\/978-1-4899-0179-8_12"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1021\/jf010923t","article-title":"Antithrombotic lipid minor constituents from vegetable oils. Comparison between olive oils and others","volume":"50","author":"Karantonis","year":"2002","journal-title":"J. Agric. Food Chem."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1740-0929.2012.01067.x","article-title":"Hen egg yolk lipid fractions with antiatherogenic properties","volume":"84","author":"Nasopoulou","year":"2013","journal-title":"Anim. Sci. J."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s13594-015-0266-x","article-title":"Evaluation of the in vitro anti-atherogenic activities of goat milk and goat dairy products","volume":"96","author":"Poutzalis","year":"2016","journal-title":"Dairy Sci. Technol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s13594-014-0161-x","article-title":"In vitro anti-atherogenic properties of traditional Greek cheese lipid fractions","volume":"94","author":"Tsorotioti","year":"2014","journal-title":"Dairy Sci. Technol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"e00227","DOI":"10.1016\/j.heliyon.2016.e00227","article-title":"Evaluation of sensory and in vitro anti-thrombotic properties of traditional Greek yogurts derived from different types of milk","volume":"3","author":"Megalemou","year":"2017","journal-title":"Heliyon"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0049-3848(83)90027-0","article-title":"Effects of garlic extract and of three pure components isolated from it on human platelet aggregation, arachidonate metabolism, release reaction and platelet ultrastructure","volume":"32","author":"Cabrera","year":"1983","journal-title":"Thromb. Res."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0021-9150(90)90046-L","article-title":"Inhibition of cyclooxygenase-independent platelet aggregation by low vitamin E concentration","volume":"82","author":"Violi","year":"1990","journal-title":"Atherosclerosis"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0049-3848(90)90233-3","article-title":"Inhibitory effect of vitamin E (alpha-tocopherol) on spontaneous platelet aggregation in whole blood","volume":"60","author":"Kakishita","year":"1990","journal-title":"Thromb. Res."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3892\/ijo.2016.3519","article-title":"Platelet-activating factor receptor activation promotes prostate cancer cell growth, invasion and metastasis via ERK1\/2 pathway","volume":"49","author":"Ji","year":"2016","journal-title":"Int. J. Oncol."},{"key":"ref_170","first-page":"27","article-title":"Biomarkers and Targeted Therapy in Pancreatic Cancer","volume":"8","author":"Karandish","year":"2016","journal-title":"Biomarkers Cancer"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3892\/or.2015.4387","article-title":"Platelet-activating factor promotes motility in breast cancer cells and disrupts non-transformed breast acinar structures","volume":"35","author":"Anandi","year":"2016","journal-title":"Oncol. Rep."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1016\/j.febslet.2015.09.022","article-title":"Emerging targets for combination therapy in melanomas","volume":"589","author":"Tortelli","year":"2015","journal-title":"FEBS Lett."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"982","DOI":"10.2174\/1389450115666140903111812","article-title":"PAF receptor and tumor growth","volume":"15","author":"Jancar","year":"2014","journal-title":"Curr. Drug Targets"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4137\/CGM.S14501","article-title":"Systemic Platelet-activating Factor Receptor Activation Augments Experimental Lung Tumor Growth and Metastasis","volume":"7","author":"Hackler","year":"2014","journal-title":"Cancer Growth Metastasis"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13046-014-0085-6","article-title":"Transactivation of epidermal growth factor receptor through platelet-activating factor\/receptor in ovarian cancer cells","volume":"33","author":"Yu","year":"2014","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Shida-Sakazume, T., Endo-Sakamoto, Y., Unozawa, M., Fukumoto, C., Shimada, K., Kasamatsu, A., Ogawara, K., Yokoe, H., Shiiba, M., and Tanzawa, H. (2015). Lysophosphatidylcholine acyltransferase1 overexpression promotes oral squamous cell carcinoma progression via enhanced biosynthesis of platelet-activating factor. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0120143"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/bjc.2013.480","article-title":"Effects of platelet-activating factor and its differential regulation by androgens and steroid hormones in prostate cancers","volume":"109","author":"Xu","year":"2013","journal-title":"Br. J. Cancer"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"C951","DOI":"10.1152\/ajpcell.00218.2014","article-title":"Enhanced breast cancer cell adherence to the lung endothelium via PAF acetylhydrolase inhibition: A potential mechanism for enhanced metastasis in smokers","volume":"307","author":"Kispert","year":"2014","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Kispert, S., Marentette, J., and McHowat, J. (2015). Cigarette smoke induces cell motility via platelet-activating factor accumulation in breast cancer cells: A potential mechanism for metastatic disease. Physiol. Rep., 3.","DOI":"10.14814\/phy2.12318"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fonc.2018.00010","article-title":"Platelet-Activating Factor Receptor Ligands Protect Tumor Cells from Radiation-Induced Cell Death","volume":"8","author":"Dalmaso","year":"2018","journal-title":"Front. Oncol."},{"key":"ref_181","first-page":"432","article-title":"PAF receptor antagonist Ginkgolide B inhibits tumourigenesis and angiogenesis in colitis-associated cancer","volume":"8","author":"Sun","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Morita, K., Shiraishi, S., Motoyama, N., Kitayama, T., Kanematsu, T., Uezono, Y., and Dohi, T. (2014). Palliation of bone cancer pain by antagonists of platelet-activating factor receptors. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0091746"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2174\/1871520614666140309222845","article-title":"Glycosidated phospholipids\u2014A promising group of anti-tumour lipids","volume":"14","author":"Semini","year":"2014","journal-title":"Anticancer Agents Med. Chem."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/ki.1986.23","article-title":"Potential role of platelet-activating factor in renal pathophysiology","volume":"29","author":"Camussi","year":"1986","journal-title":"Kidney Int."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1155\/MI.2005.263","article-title":"Characterization of acetyl-CoA: Lyso-PAF acetyltransferase of human mesangial cells","volume":"2005","author":"Fragopoulou","year":"2005","journal-title":"Mediat. Inflamm."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1046\/j.1523-1755.1999.00450.x","article-title":"Potential role of platelet activating factor in acute renal failure","volume":"55","year":"1999","journal-title":"Kidney Int."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1007\/BF02536555","article-title":"The role of platelet-activating factor (PAF) in experimental glomerular injury","volume":"26","author":"Ortiz","year":"1991","journal-title":"Lipids"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.lab.2006.01.004","article-title":"Platelet-activating factor (PAF) increase intracellular lipid accumulation by increasing both LDL and scavenger receptors in human mesangial cells","volume":"147","author":"Fragopoulou","year":"2006","journal-title":"J. Lab. Clin. Med."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/labinvest.2013.155","article-title":"Activation of platelet-activating factor receptor exacerbates renal inflammation and promotes fibrosis","volume":"94","author":"Braga","year":"2014","journal-title":"Lab. Investig."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"5563","DOI":"10.1007\/s12035-016-0062-5","article-title":"Current Understanding of Platelet-Activating Factor Signaling in Central Nervous System Diseases","volume":"54","author":"Liu","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0301-0082(96)00047-0","article-title":"Platelet-activating factor in the CNS","volume":"50","author":"Maclennan","year":"1996","journal-title":"Prog. Neurobiol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1248\/bpb.34.1159","article-title":"Platelet-activating factor and pain","volume":"34","author":"Tsuda","year":"2011","journal-title":"Biol. Pharm. Bull."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.neuroscience.2018.02.039","article-title":"Effects of Platelet-Activating Factor on Brain Microvascular Endothelial Cells","volume":"377","author":"Brailoiu","year":"2018","journal-title":"Neuroscience"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.foodchem.2017.06.038","article-title":"Seasonal variation of polar lipid content in bovine milk","volume":"237","author":"Liu","year":"2017","journal-title":"Food Chem."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0301-0082(02)00015-1","article-title":"The CNS effects of Ginkgo biloba extracts and ginkgolide B","volume":"67","author":"Maclennan","year":"2002","journal-title":"Prog. Neurobiol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.advms.2017.12.003","article-title":"Markers of anaphylaxis\u2014A systematic review","volume":"63","author":"Klimek","year":"2018","journal-title":"Adv. Med. Sci."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2249.2008.03714.x","article-title":"Allergy and the cardiovascular system","volume":"153","author":"Triggiani","year":"2008","journal-title":"Clin. Exp. Immunol."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2174\/187221308783399306","article-title":"Platelet-activating factor (PAF): A review of its role in asthma and clinical efficacy of PAF antagonists in the disease therapy","volume":"2","author":"Brzoza","year":"2008","journal-title":"Rec. Patents on Inflammation Allergy Drug Discovery"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s10753-007-9056-9","article-title":"Platelet activating factor as a mediator and therapeutic approach in bronchial asthma","volume":"31","author":"Brzoza","year":"2008","journal-title":"Inflammation"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1177\/0394632015600598","article-title":"Platelet activating factor in allergies","volume":"28","author":"Palgan","year":"2015","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejphar.2015.02.058","article-title":"Sphingosine-1-phosphate and other lipid mediators generated by mast cells as critical players in allergy and mast cell function","volume":"778","author":"Kulinski","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF03168446","article-title":"Role of histamine and platelet-activating factor in allergic rhinitis","volume":"60","author":"Alfaro","year":"2004","journal-title":"J. Physiol. Biochem."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fmed.2017.00103","article-title":"Bidirectional Mast Cell-Eosinophil Interactions in Inflammatory Disorders and Cancer","volume":"4","author":"Galdiero","year":"2017","journal-title":"Front. Med."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1398-9995.2008.01640.x","article-title":"Rupatadine in allergic rhinitis and chronic urticaria","volume":"63","author":"Mullol","year":"2008","journal-title":"Allergy"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1080\/14740338.2016.1221399","article-title":"Rupatadine: Global safety evaluation in allergic rhinitis and urticaria","volume":"15","author":"Bachert","year":"2016","journal-title":"Expert Opin. Drug. Saf."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.phrs.2016.04.005","article-title":"Opportunities for the development of novel therapies based on host-microbial interactions","volume":"112","author":"Santos","year":"2016","journal-title":"Pharmacol. Res."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/thoraxjnl-2012-202206","article-title":"The platelet activating factor receptor: A new anti-infective target in respiratory disease?","volume":"67","author":"Grigg","year":"2012","journal-title":"Thorax"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/1721727X1100900303","article-title":"PAF-metabolic enzymes and PAF-like activity in L. infantum and L. major promastigotes","volume":"9","author":"Chatzovoulos","year":"2011","journal-title":"Eur. J. Inflamm."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00024382-199706000-00001","article-title":"Platelet-activating factor (PAF) in experimental and clinical sepsis","volume":"7","author":"Mathiak","year":"1997","journal-title":"Shock"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.thromres.2013.07.002","article-title":"Use of antiplatelet agents in sepsis: A glimpse into the future","volume":"133","author":"Akinosoglou","year":"2014","journal-title":"Thromb. Res."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/jac\/41.suppl_1.81","article-title":"Therapeutic options directed against platelet activating factor, eicosanoids and bradykinin in sepsis","volume":"41","author":"Fink","year":"1998","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"980","DOI":"10.2337\/diacare.28.4.980","article-title":"The role of platelet-activating factor in pathogenesis of type 1 diabetes","volume":"28","author":"Ersoy","year":"2005","journal-title":"Diabetes Care"},{"key":"ref_213","first-page":"251","article-title":"Disturbances of the coagulating equilibrium of blood in diabetes mellitus","volume":"37","author":"Sfredel","year":"1999","journal-title":"Rev. Roum. Med. Intern."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0090-6980(98)00074-4","article-title":"Urinary platelet-activating factor excretion is elevated in non-insulin dependent diabetes mellitus","volume":"57","author":"Kudolo","year":"1999","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3748\/wjg.v12.i4.539","article-title":"Role of platelet-activating factor in the pathogenesis of acute pancreatitis","volume":"12","author":"Liu","year":"2006","journal-title":"World J. Gastroenterol."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.3748\/wjg.14.4735","article-title":"Therapy for acute pancreatitis with platelet-activating factor receptor antagonists","volume":"14","author":"Chen","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.3748\/wjg.v12.i23.3695","article-title":"Platelet-activating factor in liver injury: A relational scope","volume":"12","author":"Karidis","year":"2006","journal-title":"World J. Gastroenterol."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/j.sempedsurg.2013.01.005","article-title":"Necrotizing enterocolitis: Pathophysiology, platelet-activating factor, and probiotics","volume":"22","author":"Frost","year":"2013","journal-title":"Semin. Pediatr. Surg."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1651-2227.2002.tb00151.x","article-title":"Role of platelet-activating factor in the pathophysiology of necrotizing enterocolitis","volume":"91","author":"Ewer","year":"2002","journal-title":"Acta Paediatr. Suppl."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1517\/14728222.2012.712961","article-title":"Ocular actions of platelet-activating factor: Clinical implications","volume":"16","author":"Nitoda","year":"2012","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3109\/13813455.2012.665463","article-title":"Platelet-mediated vascular dysfunction during acute lung injury","volume":"118","author":"Dixon","year":"2012","journal-title":"Arch. Physiol. Biochem."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2174\/187152809788681010","article-title":"Platelet activating factor\/platelet activating factor receptor pathway as a potential therapeutic target in autoimmune diseases","volume":"8","author":"Edwards","year":"2009","journal-title":"Inflamm. Allergy Drug Targets"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1046\/j.1365-2249.2000.01392.x","article-title":"IL-10 stimulates production of platelet-activating factor by monocytes of patients with active systemic lupus erythematosus (SLE)","volume":"122","author":"Bussolati","year":"2000","journal-title":"Clin. Exp. Immunol."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00384-002-0408-5","article-title":"Crohn\u2019s disease: In defense of a microvascular aetiology","volume":"17","author":"Thornton","year":"2002","journal-title":"Int. J. Colorectal Dis."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0022-3565(25)20259-2","article-title":"Platelet-activating factor receptor blocking reduces proteinuria and improves survival in lupus autoimmune mice","volume":"258","author":"Morigi","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/ki.1990.309","article-title":"Platelet activating factor receptor blockade ameliorates murine systemic lupus erythematosus","volume":"38","author":"Baldi","year":"1990","journal-title":"Kidney Int."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.diabres.2005.09.003","article-title":"Effect of fast-food Mediterranean-type diet on type 2 diabetics and healthy human subjects\u2019 platelet aggregation","volume":"72","author":"Karantonis","year":"2006","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1089\/jmf.2006.9.356","article-title":"Effect of traditional Greek Mediterranean meals on platelet aggregation in normal subjects and in patients with type 2 diabetes mellitus","volume":"9","author":"Antonopoulou","year":"2006","journal-title":"J. Med. Food"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.metabol.2011.07.006","article-title":"Mediterranean wild plants reduce postprandial platelet aggregation in patients with metabolic syndrome","volume":"61","author":"Fragopoulou","year":"2012","journal-title":"Metabolism"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.4155\/fmc-2016-0072","article-title":"Cytokines: Roles in atherosclerosis disease progression and potential therapeutic targets","volume":"8","author":"Moss","year":"2016","journal-title":"Fut. Med. Chem."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/med.21251","article-title":"Eicosanoids and Their Drugs in Cardiovascular Diseases: Focus on Atherosclerosis and Stroke","volume":"33","author":"Capra","year":"2013","journal-title":"Med. Res. Rev."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/MOL.0b013e32833f2fcb","article-title":"Modified phospholipids as anti-inflammatory compounds","volume":"21","author":"Feige","year":"2010","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.3168\/jds.2016-12224","article-title":"Invited review: The anti-inflammatory properties of dairy lipids","volume":"100","author":"Lordan","year":"2017","journal-title":"J. Dairy Sci."},{"key":"ref_234","doi-asserted-by":"crossref","unstructured":"Lordan, R., and Zabetakis, I. (2017). Ovine and caprine lipids promoting cardiovascular health in milk and its derivatives. Adv. Dairy Res., 5.","DOI":"10.4172\/2329-888X.1000176"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.2174\/0929867321666140414103455","article-title":"Subfractions and subpopulations of HDL: An update","volume":"21","author":"Rizzo","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1194\/jlr.R045492","article-title":"To hydrolyze or not to hydrolyze: The dilemma of platelet-activating factor acetylhydrolase","volume":"55","author":"Marathe","year":"2014","journal-title":"J. Lipid Res."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/bph.13708","article-title":"Bioactive polyphenols and cardiovascular disease: Chemical antagonists, pharmacological agents or xenobiotics that drive an adaptive response?","volume":"174","author":"Goszcz","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1001\/jama.2012.14805","article-title":"Multivitamins in the prevention of cardiovascular disease in men: The physicians\u2019 health study II randomized controlled trial","volume":"308","author":"Sesso","year":"2012","journal-title":"JAMA"},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.2337\/diacare.25.11.1919","article-title":"Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: Results of the HOPE study and MICRO-HOPE substudy","volume":"25","author":"Lonn","year":"2002","journal-title":"Diabetes Care"},{"key":"ref_240","doi-asserted-by":"crossref","unstructured":"The Heart Outcomes Prevention Evaluation Study Investigators (2000). Vitamin E Supplementation and Cardiovascular Events in High-Risk Patients. NEMJ, 342, 154\u2013160.","DOI":"10.1056\/NEJM200001203420302"},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3389\/fcvm.2015.00029","article-title":"Antioxidants in cardiovascular therapy: Panacea or false hope?","volume":"2","author":"Goszcz","year":"2015","journal-title":"Front. Cardiovas. Med."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/sj.ejcn.1601162","article-title":"Fruit and vegetable intake and population glycosylated haemoglobin levels: The EPIC-Norfolk Study","volume":"55","author":"Sargeant","year":"2001","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_243","doi-asserted-by":"crossref","unstructured":"Myung, S.-K., Ju, W., Cho, B., Oh, S.-W., Park, S.M., Koo, B.-K., and Park, B.-J. (2013). Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: Systematic review and meta-analysis of randomised controlled trials. Br. Med. J., 346.","DOI":"10.1136\/bmj.f10"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1136\/bmj.310.6994.1563","article-title":"Vitamin C and risk of death from stroke and coronary heart disease in cohort of elderly people","volume":"310","author":"Gale","year":"1995","journal-title":"BMJ"},{"key":"ref_245","first-page":"1","article-title":"Mediterranean diet and its protective mechanisms against cardiovascular disease: An insight into Platelet Activating Factor (PAF) and diet interplay","volume":"2","author":"Detopoulou","year":"2015","journal-title":"Ann. Nutr. Disord. Ther."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1177\/0091270005279636","article-title":"Pharmacokinetics of Anthocyanins and Ellagic Acid in Healthy Volunteers Fed Freeze-Dried Black Raspberries Daily for 7 Days","volume":"45","author":"Stoner","year":"2005","journal-title":"J. Clin. Pharmacol."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/10\/5\/604\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:04:01Z","timestamp":1760195041000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/10\/5\/604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,12]]},"references-count":246,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5]]}},"alternative-id":["nu10050604"],"URL":"https:\/\/doi.org\/10.3390\/nu10050604","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,12]]}}}